Normal range estimation for repeated immunologic measures

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 2, 1996, Pages 139-142

  Taylor, Jeremy M G ^a   Cumberland, William G ^a   Meng, Xiangyi ^a   Giorgi, Janis V ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN;

ADULT; ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NORMAL HUMAN; NORMAL VALUE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029864108     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.2.139-142.1996     Document Type: Article

References (17)

1. Cumberland, W. G., J. M. G. Taylor, and X. Y. Meng. Nonparametric normal range estimation for repeated measures. Submitted for publication.
2. Gelman, R., and L. Eudey. 1989. Biostatistical considerations for quality assessment of immunologic measurements used in clinical and longitudinal studies. Clin. Immunol. Immunopathol. 58:28-37.
3. Giorgi, J. V., and R. Detels. 1989. T cells subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS Cohort Study. Clin. Immunol. Immunopathol. 52:10-18.
4. + T cell levels: results of 6 years of follow-up. J. Acquired Immune Defic. Syndr. 6:904-912.
5. Hamilton, S. A., and J. M. G. Taylor. 1993. A comparison of the Box-Cox transformation method and nonparametric methods for estimating quantites in clinical data with repeated measures. J. Statist. Comput. Simulation 45:185-201.
6. Harrell, F. E., and C. E. Davis. 1982. A new distribution free quantile estimator. Biometrika 69:635-640.
7. Harris, E. K., and D. L. DeMets. 1972. Estimation of normal ranges and cumulative proportions by transforming observed distributions to Gaussian form. Clin. Chem. 18:605-612.
8. + cytotoxic T cells express CD38 and HLA-DR antigens. J. Immunol. 150:3070-3079.
9. Levacher, M., F. Hulstaert, S. Tallet, S. Ullery, J. J. Pocidalo, and J. S. Bach. 1992. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin. Exp. Immunol. 90:376-382.
10. + T cells and risk of developing AIDS in HIV infection. Submitted for publication.
11. + T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up. Comm. Clin. Cytom., in press.
12. Peddecord, K. M., A. S. Beneson, L. K. Hofherr, D. P. Francis, R. S. Garfein, G. D. Cross, and W. O. Schalla. 1993. Variability of reporting and lack of adherence to consensus guidelines in human T-lymphocyte immunophenotyping reports: results of a case series. J. Acquired Immune Defic. Syndr. 6:823-830.
13. Reed, A. H., R. J. Henry, and W. B. Mason. 1971. Influence of statistical method used on the resulting estimate of normal ranged Clin. Chem. 20:576-581.
14. Salazar-Gonzalez, J. F., D. J. Moody, J. V. Giorgi, O. Martinez-Maza, R. T. Mitsuyasu, and J. L. Fahey. 1985. Reduced ECTO-5′-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CDS (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity. J. Immunol. 133:1778-1785.
15. SAS Institute Inc. 1990. SAS procedures guide, version 6, 3rd ed. SAS Institute, Inc., Cary, N.C.
16. Tango, T. 1986. Estimation of normal ranges in clinical laboratory data. Stat. Med. 5:335-346.
17. Taylor, J. M. G., R. Afrisiabi, J. L. Fahey, L. P. Korns, M. Weaver, and R. T. Mitsuyasu. 1986. A prognostically significant classification of immune changes in AIDS with Kaposi's sarcoma. Blood 67:666-671.